Donald V. Cramer

3.6k total citations
155 papers, 2.9k citations indexed

About

Donald V. Cramer is a scholar working on Surgery, Immunology and Molecular Biology. According to data from OpenAlex, Donald V. Cramer has authored 155 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Surgery, 60 papers in Immunology and 23 papers in Molecular Biology. Recurrent topics in Donald V. Cramer's work include T-cell and B-cell Immunology (43 papers), Xenotransplantation and immune response (43 papers) and Organ Transplantation Techniques and Outcomes (32 papers). Donald V. Cramer is often cited by papers focused on T-cell and B-cell Immunology (43 papers), Xenotransplantation and immune response (43 papers) and Organ Transplantation Techniques and Outcomes (32 papers). Donald V. Cramer collaborates with scholars based in United States, Netherlands and United Kingdom. Donald V. Cramer's co-authors include L Makowka, Thomas J. Gill, Haval Shirwan, Thomas E. Starzl, Heinz W. Kunz, John W. Shonnard, Gordon D. Wu, Vaughn A. Starnes, F Chapman and Mark L. Barr and has published in prestigious journals such as The Journal of Immunology, Hepatology and Annals of the New York Academy of Sciences.

In The Last Decade

Donald V. Cramer

150 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Donald V. Cramer United States	30	1.4k	941	591	421	418	155	2.9k
Agustin P. Dalmasso United States	40	2.8k 2.0×	1.7k 1.8×	784 1.3×	1.2k 2.9×	382 0.9×	122	5.3k
Richard A. Sidner United States	25	1.4k 1.0×	267 0.3×	520 0.9×	716 1.7×	426 1.0×	46	2.3k
G. Alex Bishop Australia	29	908 0.7×	1.2k 1.3×	367 0.6×	116 0.3×	761 1.8×	62	2.7k
Henry J. Winn United States	35	1.6k 1.2×	2.3k 2.4×	785 1.3×	494 1.2×	834 2.0×	81	4.3k
Reinhard Schwinzer Germany	32	1.1k 0.8×	1.1k 1.2×	1.1k 1.9×	1.0k 2.4×	240 0.6×	104	3.0k
Erna Möller Sweden	32	439 0.3×	1.6k 1.7×	467 0.8×	332 0.8×	237 0.6×	118	2.8k
Michel Awwad United States	39	3.2k 2.4×	1.1k 1.1×	1.1k 1.9×	1.9k 4.6×	229 0.5×	93	4.7k
Giorgio Raimondi United States	28	416 0.3×	1.9k 2.0×	700 1.2×	176 0.4×	343 0.8×	67	3.1k
D. Keith Bishop United States	34	560 0.4×	2.0k 2.2×	819 1.4×	419 1.0×	363 0.9×	88	3.6k
Oliver A. Garden United Kingdom	29	367 0.3×	1.2k 1.3×	888 1.5×	293 0.7×	84 0.2×	102	3.1k

Countries citing papers authored by Donald V. Cramer

Since Specialization

Citations

This map shows the geographic impact of Donald V. Cramer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donald V. Cramer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donald V. Cramer more than expected).

Fields of papers citing papers by Donald V. Cramer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donald V. Cramer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donald V. Cramer. The network helps show where Donald V. Cramer may publish in the future.

Co-authorship network of co-authors of Donald V. Cramer

This figure shows the co-authorship network connecting the top 25 collaborators of Donald V. Cramer. A scholar is included among the top collaborators of Donald V. Cramer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donald V. Cramer. Donald V. Cramer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kearns‐Jonker, Mary, Jacqueline Fischer‐Lougheed, Annette Kleihauer, et al.. (2004). USE OF LENTIVIRAL VECTORS TO INDUCE LONG-TERM TOLERANCE TO GAL+ HEART GRAFTS. Transplantation. 77(11). 1748–1754. 17 indexed citations

Mitsuhashi, Noboru, Mary Kearns‐Jonker, Gordon D. Wu, et al.. (2004). Identification, functional analysis and expression in a heterotopic heart transplant model of CXCL9 in the rat. Immunology. 112(1). 87–93. 4 indexed citations

Wu, Gordon D., Thanos P. Kakoulidis, Xingyi Que, et al.. (2003). Predominant expression of the Th2 response in chronic cardiac allograft rejection. Transplant International. 16(8). 562–571. 19 indexed citations

Wakiyama, Shigeki, et al.. (1999). GENETIC CONTROL OF THE HUMORAL RESPONSES TO XENOGRAFTS. III. IDENTIFICATION OF THE IMMUNOGLOBULIN VH GENES RESPONSIBLE FOR ENCODING RAT IMMUNOGLOBIN G XENOANTIBODIES TO HAMSTER HEART GRAFTS1. Transplantation. 68(1). 15–24. 8 indexed citations

Cramer, Donald V.. (1996). Brequinar sodium.. PubMed. 28(2). 960–3.

Shirwan, Haval, et al.. (1996). PRETRANSPLANT INJECTION OF ALLOGRAFT RECIPIENTS WITH DONOR BLOOD OR LYMPHOCYTES PERMITS ALLOGRAFT TOLERANCE WITHOUT THE PRESENCE OF PERSISTENT DONOR MICROCHIMERISM1. Transplantation. 61(9). 1382–1386. 43 indexed citations

Cosenza, Carlos Alberto Nunes, et al.. (1994). Combination therapy with Brequinar sodium and cyclosporine synergistically prolongs hamster-to-rat cardia xenograft survival.. PubMed. 13(3). 489–97. 8 indexed citations

Shirwan, Haval, L Makowka, Elizabeth P. Blankenhorn, & Donald V. Cramer. (1994). Polymerase chain reaction detection of chimerism in rats based on an allelic polymorphism for T cell antigen receptor Cβ genes. Transplant Immunology. 2(3). 253–256. 7 indexed citations

Yasunaga, Chikao, Donald V. Cramer, Carlos Alberto Nunes Cosenza, et al.. (1993). Effect of brequinar sodium on in vivo antibody production.. PubMed. 25(3 Suppl 2). 40–4. 6 indexed citations

10.

Cosenza, Carlos Alberto Nunes, Phillip Tuso, F Chapman, et al.. (1993). Prolonged xenograft survival following combination therapy with brequinar sodium and cyclosporine.. PubMed. 25(3 Suppl 2). 59–60. 6 indexed citations

11.

Jaffee, Bruce, Emma Jones, Ian Zajac, et al.. (1993). Effects of brequinar sodium on cynomolgus monkeys: immunosuppression and pharmacokinetics.. PubMed. 25(1 Pt 1). 710–1. 4 indexed citations

12.

Makowka, L, et al.. (1993). Historical development of brequinar sodium as a new immunosuppressive drug for transplantation.. PubMed. 25(3 Suppl 2). 2–7. 20 indexed citations

13.

Yasunaga, Chikao, et al.. (1993). Cardiac graft rejection in hypersensitized recipients: prevention of antibody response and graft rejection using brequinar sodium.. PubMed. 25(3 Suppl 2). 65–6. 1 indexed citations

14.

Knoop, M., et al.. (1993). Brequinar sodium suppresses liver allograft rejection and induces permanent tolerance in the rat.. PubMed. 25(1 Pt 1). 706–7. 2 indexed citations

15.

Cramer, Donald V., F Chapman, & L Makowka. (1993). Prevention of vascularized allograft and xenograft rejection in rodents by brequinar sodium.. PubMed. 25(3 Suppl 2). 23–8. 3 indexed citations

16.

Cramer, Donald V., F Chapman, Bruce Jaffee, et al.. (1992). The effect of a new immunosuppressive drug, brequinar sodium, on concordant hamster-to-rat cardiac xenografts.. PubMed. 24(2). 720–1. 8 indexed citations

17.

Hoffman, Allen, L Makowka, Donald V. Cramer, et al.. (1989). Immunomagnetic T-Lymphocyte Depletion (ITLD) of Rat Bone Marrow Using OX-19 Monoclonal Antibody. Journal of Investigative Surgery. 2(3). 241–251. 2 indexed citations

18.

Gill, Thomas J., et al.. (1978). The major histocompatibility complex--comparison in the mouse, man, and the rat. A review.. The Mouseion at the JAXlibrary (Jackson Laboratory). 7 indexed citations

19.

Cramer, Donald V. & Thomas J. Gill. (1975). MATERNAL INFLUENCE ON POSTIMPLANTATION SURVIVAL IN INBRED RATS. Reproduction. 44(2). 317–321. 3 indexed citations

20.

Cramer, Donald V. & Robert M. Lewis. (1972). Reticulocyte Response in the Cat. Journal of the American Veterinary Medical Association. 160(1). 61–67. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact